Australia Markets open in 3 hrs 41 mins

Genmab A/S (GMAB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
37.54-0.03 (-0.08%)
As of 03:19PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.67
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 347.50
52-week low 326.19
50-day moving average 337.82
200-day moving average 337.71

Share statistics

Avg vol (3-month) 3538.09k
Avg vol (10-day) 3500.97k
Shares outstanding 5659.62M
Implied shares outstanding 6N/A
Float 8645.07M
% held by insiders 10.00%
% held by institutions 16.92%
Shares short (12 Jan 2023) 43.13M
Short ratio (12 Jan 2023) 44.44
Short % of float (12 Jan 2023) 4N/A
Short % of shares outstanding (12 Jan 2023) 40.47%
Shares short (prior month 14 Dec 2022) 43.21M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 25:1
Last split date 330 Apr 2018

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 47.17%
Operating margin (ttm)37.55%

Management effectiveness

Return on assets (ttm)10.29%
Return on equity (ttm)23.59%

Income statement

Revenue (ttm)11.99B
Revenue per share (ttm)18.32
Quarterly revenue growth (yoy)76.90%
Gross profit (ttm)8.48B
EBITDA 4.76B
Net income avi to common (ttm)5.65B
Diluted EPS (ttm)0.66
Quarterly earnings growth (yoy)190.10%

Balance sheet

Total cash (mrq)23.79B
Total cash per share (mrq)36.47
Total debt (mrq)629M
Total debt/equity (mrq)2.36
Current ratio (mrq)9.62
Book value per share (mrq)32.55

Cash flow statement

Operating cash flow (ttm)3.76B
Levered free cash flow (ttm)2.44B